Position in VTRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$851,642
+$43,395 QoQ
Shares Held
53,630
-10.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#335
of 1,020 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rockefeller Capital Management L.P. holds $105,853,317 across 51 Drug Manufacturers - Specialty & Generic names. VTRS ranks #6 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
373,548 | $62,957,776 | |
| 2 | ZTS |
Zoetis Inc.
|
330,418 | $23,743,834 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
173,438 | $11,091,360 | |
| 4 | HLN |
Haleon plc
|
122,399 | $1,141,981 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
29,716 | $1,030,252 | |
| 6 | VTRS |
Viatris Inc
This page
|
53,630 | $851,642 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
1,506 | $815,994 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
25,940 | $638,382 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $851,642 | 53,630 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $808,247 | 59,826 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $603,139 | 48,445 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $451,241 | 45,580 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $375,291 | 42,026 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $242,581 | 27,851 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $368,071 | 29,564 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $383,627 | 33,043 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $316,496 | 29,774 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $393,577 | 32,963 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $428,325 | 39,550 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $375,703 | 38,104 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $225,916 | 22,637 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $271,091 | 28,316 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $324,630 | 29,432 | Shares | Defined | 2023-03-06 | |
| 2022-09-30 | $285,614 | 33,523 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $341,519 | 32,619 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $380,918 | 35,011 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $453,660 | 33,530 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $534,274 | 39,430 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $698,564 | 48,885 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $650,204 | 46,543 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $1,961,945 | 104,693 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||